Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS fell 500.0%, free cash flow fell 60.6% and total debt rose 4.92%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

14.64 0.13 −0.88%
Market cap
$1.9B
P/E
0.0×
Fwd P/E
−94.9×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.64 0.46 0.59 0.84
P/FCF ratio
11.30 6.13 8.12 11.56
P/Operating CF
36.50 130.78 19.01 32.93
P/B ratio
0.70 0.49 0.63 0.88
EV/Sales
1.69 1.51 1.64 1.86
EV/EBITDA
9.77 8.54 9.22 10.54
EV/FCF
29.76 20.27 22.42 25.67
Current Ratio
1.95 1.86 1.87 1.88
Net Debt/EBITDA
23.91 32.58 19.59 22.34
Debt/Equity
1.21 1.20 1.18 1.13
Earnings Yield
(4.17%) (5.03%) (4.01%) (6.28%)
Free Cash Flow Yield
8.85% 16.32% 12.32% 8.65%
Free Cash Flow per Share
0.29 (0.03) 0.74 0.50
Book value per Share
24.08 24.13 24.62 24.70
Free Cash Flow
37.80 (4.30) 94.20 63.80
EV/EBIT
14.03 12.20 13.16 14.22
Other line items

Show all line items

Columns are period end dates